Filing Details

Accession Number:
0001225208-18-005273
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-05 16:20:50
Reporting Period:
2018-03-01
Accepted Time:
2018-03-05 16:20:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629277 Bradley John Sorenson 300 Boston Scientific Way
Marlborough MA 01752-1234
Svp, Manuf & Sup Chn No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-01 2,800 $17.26 45,436 No 4 M Direct
Common Stock Acquisiton 2018-03-01 2,600 $16.31 48,036 No 4 M Direct
Common Stock Acquisiton 2018-03-01 2,500 $13.08 50,536 No 4 M Direct
Common Stock Acquisiton 2018-03-01 2,400 $24.55 52,936 No 4 M Direct
Common Stock Disposition 2018-03-01 3,850 $27.00 49,086 No 4 S Direct
Common Stock Disposition 2018-03-01 10,300 $26.99 38,786 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-03-01 2,800 $0.00 2,800 $17.26
Common Stock Stock Option (Right to Buy) Disposition 2018-03-01 2,600 $0.00 2,600 $16.31
Common Stock Stock Option (Right to Buy) Disposition 2018-03-01 2,500 $0.00 2,500 $13.08
Common Stock Stock Option (Right to Buy) Disposition 2018-03-01 2,400 $0.00 2,400 $24.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,587 2026-02-22 No 4 M Direct
16,351 2025-02-23 No 4 M Direct
15,000 2024-02-24 No 4 M Direct
17,362 2027-02-28 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.83 to $27.30, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the grant.
  4. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the grant.
  5. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
  6. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the grant.